Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Has Average Target Price of $14.25

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $14.25.

A number of brokerages recently weighed in on AVAH. Royal Bank Of Canada restated an “outperform” rating on shares of Aveanna Healthcare in a research note on Friday. Truist Financial raised their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, August 24th. JPMorgan Chase & Co. boosted their price target on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, September 14th. BMO Capital Markets upped their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Finally, Weiss Ratings upgraded shares of Aveanna Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 14th.

Trending Headlines about Aveanna Healthcare

Investors following AVAH have been watching these headlines:

• Positive Sentiment: Aveanna raised its 2026 guidance; its revenue outlook is $2.7 billion, broadly in line with consensus. Investors may also see potential support from growth and operational efficiencies, as well as a planned California rate increase in 2027. Aveanna Healthcare: Revenue Growth, Guidance Raises, Yet Shares Still Trade At A Discount
• Negative Sentiment: The company froze a planned California nurse base-wage increase amid uncertainty around state reimbursement rates. Wage pressure and uncertainty over when rate increases will take effect could constrain margins. Aveanna Freezes California Nurse Base Wage Hike Amid Rate Uncertainty
• Negative Sentiment: Aveanna reported goodwill, intangible and other long-lived asset impairment for the quarter. Separately, an analysis notes that leverage and exposure to Medicaid remain investor concerns despite the company’s growth and valuation discount. Aveanna Reports Asset Impairment

Aveanna Healthcare Stock Performance

AVAH stock traded down $0.74 on Friday, reaching $11.50. The company’s stock had a trading volume of 4,266,299 shares, compared to its average volume of 2,149,174. Aveanna Healthcare has a 52 week low of $5.93 and a 52 week high of $14.71. The company has a market capitalization of $2.51 billion, a P/E ratio of 8.39, a price-to-earnings-growth ratio of 0.75 and a beta of 2.03. The firm has a fifty day moving average of $13.02 and a two-hundred day moving average of $9.46. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, November 12th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.02. Aveanna Healthcare had a return on equity of 70.01% and a net margin of 11.44%. The company had revenue of $695.54 million during the quarter, compared to analyst estimates of $679.48 million. As a group, analysts predict that Aveanna Healthcare will post 0.77 EPS for the current fiscal year.

Insider Activity

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. This represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Edwin Reisz sold 50,000 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $575,000.00. Following the transaction, the insider directly owned 1,397,897 shares of the company’s stock, valued at approximately $16,075,815.50. The trade was a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 48,566,081 shares of company stock valued at $558,509,932 over the last 90 days. Corporate insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Marshall Wace LLP acquired a new position in shares of Aveanna Healthcare in the 3rd quarter valued at $59,731,000. Caxton Associates LLP acquired a new stake in Aveanna Healthcare during the 3rd quarter worth about $2,503,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Aveanna Healthcare during the 3rd quarter worth about $3,046,000. State Board of Administration of Florida Retirement System increased its position in shares of Aveanna Healthcare by 56.7% in the third quarter. State Board of Administration of Florida Retirement System now owns 124,644 shares of the company’s stock worth $1,547,000 after acquiring an additional 45,087 shares in the last quarter. Finally, Bleakley Financial Group LLC acquired a new stake in shares of Aveanna Healthcare during the third quarter valued at approximately $241,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.